Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial. (Q46580236)
Jump to navigation
Jump to search
scientific article published on 20 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial. |
scientific article published on 20 May 2008 |
Statements
Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial (English)
Akihiro Tamori
Madoka Toyama Kohmoto
Takehiro Hayashi
Hiroyasu Morikawa
Hisato Jomura
Hiroki Sakaguchi
Daiki Habu
Norifumi Kawada
Susumu Shiomi
Shuhei Nishiguchi